You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation
|
|---|---|
| Published in |
Frontiers in immunology, December 2016
|
| DOI | 10.3389/fimmu.2016.00550 |
| Pubmed ID | |
| Authors |
Kankana Bardhan, Theodora Anagnostou, Vassiliki A. Boussiotis |
X Demographics
The data shown below were collected from the profiles of 19 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Switzerland | 1 | 5% |
| Mexico | 1 | 5% |
| United States | 1 | 5% |
| Venezuela, Bolivarian Republic of | 1 | 5% |
| Unknown | 15 | 79% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 16 | 84% |
| Practitioners (doctors, other healthcare professionals) | 2 | 11% |
| Scientists | 1 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 573 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | <1% |
| Norway | 1 | <1% |
| Unknown | 571 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 83 | 14% |
| Student > Bachelor | 82 | 14% |
| Student > Master | 71 | 12% |
| Researcher | 68 | 12% |
| Student > Doctoral Student | 37 | 6% |
| Other | 68 | 12% |
| Unknown | 164 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 108 | 19% |
| Medicine and Dentistry | 104 | 18% |
| Immunology and Microbiology | 74 | 13% |
| Agricultural and Biological Sciences | 44 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 20 | 3% |
| Other | 46 | 8% |
| Unknown | 177 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 31. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 June 2023.
All research outputs
#1,335,062
of 26,168,182 outputs
Outputs from Frontiers in immunology
#1,188
of 33,003 outputs
Outputs of similar age
#25,932
of 424,083 outputs
Outputs of similar age from Frontiers in immunology
#12
of 264 outputs
Altmetric has tracked 26,168,182 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 33,003 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 424,083 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 264 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.